Company: NOTV
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023370
Chunk: 71

Company: Inotiv, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 71
---
 by a decrease in discovery services revenue and decreased general toxicology services revenue. 

DSA operating income decreased by $2,556 in the six months ended March 31, 2025 compared to the six months ended March 31, 2024, primarily due to the decrease in revenue discussed above, an increase of $2,568 in cost of revenue and an increase of $327 in depreciation and amortization of intangible assets, partially offset by a decrease of $3,514 in operating expenses. The increase in cost of revenue was primarily due to increased compensation and benefits expense, partially offset by a decrease in research animal model purchases. The decrease in operating expenses primarily related to decreases in compensation and benefits costs, bad debt expense and professional fees. 

RMS

Six Months EndedMarch 31,20252024$ Change% ChangeRevenue$156,045$163,207$(7,162)(4.4)%Cost of revenue1123,989130,772(6,783)(5.2)%Operating expenses23,22138,580(35,359)(91.7)%Depreciation and amortization of intangible assets18,58819,380(792)(4.1)%Operating income (loss) 3$10,247$(25,525)$35,772(140.1)%Operating income (loss) % of total revenue4.2 %(10.0)%1Cost of revenue includes cost of services provided and cost of products sold and excludes depreciation and amortization of intangible assets, which is separately stated2Operating expenses include selling, general and administrative and other operating expenses and excludes depreciation and amortization of intangible assets, which is separately stated3 Table may not foot due to rounding

RMS revenue decreased $7,162 in the six months ended March 31, 2025 compared to the six months ended March 31, 2024 due primarily to decreased NHP product and service revenue, mainly as a result of lower pricing in connection with the sale of NHPs.

RMS operating income was $10,247 in the six months ended March 31, 2025 compared to operating loss of $25,525 in the six months ended March 31, 2024, a change of $35,772. This change was primarily due to decreased operating expenses and decreased cost of revenue, partially offset by the decreased revenue discussed above. The $35,359 decrease in operating expenses was primarily due to the $26,500 million charge related to